Mucosal-Invariant T Cell Receptor Recognizes HLA-DRB1 Selected SARS-Epitopes

Authors

  • Subhajit Dasgupta

  • Shaoni Dasgupta

  • Mausumi Bandyopadhyay

Keywords:

SARCOV2; Spike peptides; Epitope; HLA-DR; T cell, T cell receptor, mucosa

Abstract

Infection of SARS-COV2 and its variants causes wide range morbidity and mortality in recent years. Identification of epitope-based mechanism of viral infection with progressive fatality and antiviral immunotherapy are two major goals to address population-bias immune response. We selected peptides from SARS-COV2 Spike (6VXX_A), Delta (B.1.617.2), Omicron (B.1.1.529) proteins. These peptides contain epitopes which are identified as low rank good fit immunogenic as recognized more by HLA-DRB1*15:01, than HLA-DRB1*07:01 and HLA-DRB1*03:01. We also found the selected epitopes specifically form interactive complex with mucosa-associated invariant T cell. The Molecular Docking and Molecular Dynamics experiments demonstrated amino acid sequence-specific interaction between close atoms from epitopes and MAIT-TCR. We used virus unrelated microbial peptide antigen85 as control.

How to Cite

Mucosal-Invariant T Cell Receptor Recognizes HLA-DRB1 Selected SARS-Epitopes. (2023). Global Journal of Medical Research, 23(K2), 1-14. https://medicalresearchjournal.org/index.php/GJMR/article/view/102333

References

H Amirfakhryan, F Safari (2020) Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement.

Alexandre Belot, Denise Antona, Sylvain Renolleau, Etienne Javouhey, Véronique Hentgen, François Angoulvant, Christophe Delacourt, Xavier Iriart, Caroline Ovaert, Brigitte Bader-Meunier, Isabelle Kone-Paut, Daniel Levy-Bruhl (2020) SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. 25(22).

Feng Pan, Lian Yang, Yuncheng Li, Bo Liang, Lin Li, Tianhe Ye, Lingli Li, Dehan Liu, Shan Gui, Yu Hu, Chuansheng Zheng (2020) Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. 17(9), 1281-1292.

G De Luca, M Nardin, M Algowhary, B Uguz, D Oliveira, V Ganyukov (2022) Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry. 23(1), 207.

Manojit Bhattacharya, Srijan Chatterjee, Ashish Sharma, Sang-Soo Lee, Chiranjib Chakraborty (2022) Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape. 68(1), 17-28.

Ribeiro Xavier, C, Sachetto Oliveira, R Da, Fonseca Vieira, V Lobosco, M, Weber Santos, R (2022) Characterisation of Omicron Variant during COVID-19 Pandemic and the Impact of Vaccination, Transmission Rate, Mortality, and Reinfection in South Africa, Germany, and Brazil. 11(2).

Ling Xue, Shuanglin Jing, Kai Zhang, Russell Milne, Hao Wang (2022) Infectivity versus fatality of SARS-CoV-2 mutations and influenza. 121, 195-202.

Eduardo Antonio, Mariana Meireles, Marcelo Bragatte, Gustavo Vieira (2022) Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants. 13, 931372.

Christopher Szeto, Andrea Nguyen, Christian Lobos, Demetra Chatzileontiadou, Dhilshan Jayasinghe, Emma Grant, Alan Riboldi-Tunnicliffe, Corey Smith, Stephanie Gras (2021) Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR. 10(10), 2646.

K Wragg, W Lee, M Koutsakos, H Tan, T Amarasena, A Reynaldi (2022) Establishment and recall of SARS-CoV-2 spike epitope-specific CD4(+) T cell memory. 23(5), 768-780.

Mairpady Shambat, S Gomez-Mejia, A Schweizer, T Huemer, M Chang, C Acevedo, C (2022) Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19. 18(1), 1010176.

Didier Payen, Maxime Cravat, Hadil Maadadi, Carole Didelot, Lydia Prosic, Claire Dupuis, Marie-Reine Losser, Marcelo De Carvalho Bittencourt (2020) A Longitudinal Study of Immune Cells in Severe COVID-19 Patients. 11, 580250.

Benjamin Bonnet, Justine Cosme, Claire Dupuis, Elisabeth Coupez, Mireille Adda, Laure Calvet, Laurie Fabre, Pierre Saint-Sardos, Marine Bereiziat, Magali Vidal, Henri Laurichesse, Bertrand Souweine, Bertrand Evrard (2021) Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation. 73, 103622.

Zorana Dobrijević, Nikola Gligorijević, Miloš Šunderić, Ana Penezić, Goran Miljuš, Sergej Tomić, Olgica Nedić (2022) The association of human leucocyte antigen (HLA) alleles with COVID‐19 severity: A systematic review and meta‐analysis. 33(1), 2378.

S Dhanda, S Mahajan, S Paul, Z Yan, H Kim, M Jespersen (2019) IEDB-AR: immune epitope database-analysis resource in 2019. 47(W1), 502-W506.

Christelle Harly, Jacques Robert, Francois Legoux, Olivier Lantz (2022) γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions?. 209(2), 217-225.

Darryl Johnson, Zheng Ruan, Emma Petley, Sapna Devi, Lauren Holz, Adam Uldrich, Jeffrey Mak, Jyh Hor, Scott Mueller, James Mccluskey, David Fairlie, Phillip Darcy, Paul Beavis, William Heath, Dale Godfrey (2022) Differential location of NKT and MAIT cells within lymphoid tissue. 12(1), 4034.

Joana Dias, Caroline Boulouis, Jean-Baptiste Gorin, Robin Van Den Biggelaar, Kerri Lal, Anna Gibbs, Liyen Loh, Muhammad Gulam, Wan Sia, Sudipto Bari, William Hwang, Douglas Nixon, Son Nguyen, Michael Betts, Marcus Buggert, Michael Eller, Kristina Broliden, Annelie Tjernlund, Johan Sandberg, Edwin Leeansyah (2018) The CD4CD8MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+MAIT cell pool. 115(49), 11513-E11522.

A Kurioka, A Jahun, R Hannaway, L Walker, J Fergusson, E Sverremark-Ekstrom (2017) Shared and Distinct Phenotypes and Functions of Human CD161++ Valpha7.2+ T Cell Subsets. 8, 1031.

A Chiba, G Murayama, S Miyake (2021) Characteristics of mucosal-associated invariant T cells and their roles in immune diseases. 33(12), 775-780.

Dolaji Henin, Gaia Pellegrini, Daniela Carmagnola, Giuseppe Lanza Attisano, Gianluca Lopez, Stefano Ferrero, Antonella Amendola, Danilo De Angelis, Elisabetta Tanzi, Claudia Dellavia (2022) Morphological and Immunopathological Aspects of Lingual Tissues in COVID-19. 11(7), 1248.

Artur Słomka, Gennaro Martucci, Giuseppe Raffa, Pietro Malvindi, Ewa Żekanowska, Roberto Lorusso, Piotr Suwalski, Mariusz Kowalewski (2021) Immunological and Hematological Response in COVID-19. 1352, 73-86.

Michael Souter, Wael Awad, Shihan Li, Troi Pediongco, Bronwyn Meehan, Lucy Meehan, Zehua Tian, Zhe Zhao, Huimeng Wang, Adam Nelson, Jérôme Le Nours, Yogesh Khandokar, T Praveena, Jacinta Wubben, Jie Lin, Lucy Sullivan, George Lovrecz, Jeffrey Mak, Ligong Liu, Lyudmila Kostenko, Katherine Kedzierska, Alexandra Corbett, David Fairlie, Andrew Brooks, Nicholas Gherardin, Adam Uldrich, Zhenjun Chen, Jamie Rossjohn, Dale Godfrey, James Mccluskey, Daniel Pellicci, Sidonia Eckle (2022) CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells. 219(9).

Wael Awad, Jérôme Le Nours, Lars Kjer‐nielsen, James Mccluskey, Jamie Rossjohn (2018) Mucosal‐associated invariant T cell receptor recognition of small molecules presented by MR1. 96(6), 588-597.

Mucosal-Invariant T Cell Receptor Recognizes HLA-DRB1 Selected SARS-Epitopes

Published

2023-04-21

How to Cite

Mucosal-Invariant T Cell Receptor Recognizes HLA-DRB1 Selected SARS-Epitopes. (2023). Global Journal of Medical Research, 23(K2), 1-14. https://medicalresearchjournal.org/index.php/GJMR/article/view/102333